Fentanyl in postmortem forensic toxicology

References

• Calis KA, Kohler DR, Corso DM. Transdermally administered fentanyl for pain management. Clin Pharm 1992; 11:22–36.
   PubMedGoogle Scholar
• Poklis A. Fentanyl: a review for clinical and analytical toxicologists. J Toxicol Clin Toxicol 1995; 33:439–447.
   PubMed Web of Science ®Google Scholar
• Turock MK, Watts DJ, Mude H, Prestosh J, Stoltzfus J. Fentanyl-laced heroin: a report from an unexpected place. Am J Emerg Med 2009; 27:237–239.
   PubMed Web of Science ®Google Scholar
• Holley FO, van Steennis C. Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery. Br J Anaesth 1988; 60:608–613.
   PubMed Web of Science ®Google Scholar
• Worsley MH, MacLeod AD, Brodie MJ, Asbury AJ, Clark C. Inhaled fentanyl as a method of analgesia. Anaesthesia 1990; 45:449–451.
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Whittington D, Hoffer C. Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate. Anesthesiology 2004; 101:729–737.
   PubMed Web of Science ®Google Scholar
• Sebel PS, Barrett CW, Kirk CJ, Heykants J. Transdermal absorption of fentanyl and sufentanil in man. Eur J Clin Pharmacol 1987; 32:529–531.
   PubMed Web of Science ®Google Scholar
• Janssen Pharmaceutica Products L. Fentanyl Transdermal System: full prescribing information and patient information. Titusville, NJ: Janssen Pharmaceutica Products; 2007:1–6.
   Google Scholar
• Tharp AM, Winecker RE, Winston DC. Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches. Am J Forensic Med Pathol 2004; 25:178–181.
   PubMed Web of Science ®Google Scholar
• Prodduturi S, Sadrieh N, Wokovich AM, Doub WH, Westenberger BJ, Buhse L. Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin. J Pharm Sci 2010; 99:2357–2366.
   PubMed Web of Science ®Google Scholar
• Nelson L, Schwaner R. Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol 2009; 5:230–241.
   PubMedGoogle Scholar
• Mylan Pharmaceuticals I. Fentanyl Transdermal System: Full prescribing information and patient information. Morgantown, WV: Mylan Pharmaceuticals, Inc.; 2008:1–6.
   Google Scholar
• Plezia PM, Kramer TH, Linford J, Hameroff SR. Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluation. Pharmacotherapy 1989; 9:2–9.
   PubMed Web of Science ®Google Scholar
• Varvel JR, Shafer SL, Hwang SS, Coen PA, Stanski DR. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989; 70:928–934.
   PubMed Web of Science ®Google Scholar
• Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988; 67:329–337.
   PubMed Web of Science ®Google Scholar
• Lehmann KA, Heinrich C, van Heiss R. Balanced anesthesia and patient-controlled postoperative analgesia with fentanyl: minimum effective concentrations, accumulation and acute tolerance. Acta Anaesthesiol Belg 1988; 39:11–23.
   PubMedGoogle Scholar
• Sathyan G, Guo C, Sivakumar K, Gidwani S, Gupta S. Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications. Curr Med Res Opin 2005; 21:1961–1968.
   PubMed Web of Science ®Google Scholar
• Prodduturi S, Wokovich AM, Westenberger BJ, Buhse L, Doub WH. In vitro characterization of fentanyl transdermal systems (Abstract #: F-15) FDA Science Forum 2006; 1.
   Google Scholar
• Mills PC, Magnusson BM, Cross SE. Investigation of in vitro transdermal absorption of fentanyl from patches placed on skin samples obtained from various anatomic regions of dogs. Am J Vet Res 2004; 65:1697–1700.
   PubMed Web of Science ®Google Scholar
• Larsen RH, Nielsen F, Sorensen JA, Nielsen JB. Dermal penetration of fentanyl: inter- and intraindividual variations. Pharmacol Toxicol 2003; 93:244–248.
   PubMedGoogle Scholar
• Southwell D, Barry B, Woodford R. Variations in permeability of human skin within and between specimens. Int J Pharmaceut 1984; 18:299–309.
   Web of Science ®Google Scholar
• Grobosch T, Weniger S, Lampe D. Fentanyl analytics in a case of fatal misuse of transdermal fentanyl. Toxichem Krimtech 2007; 74:59–63.
   Google Scholar
• Anonymous. In brief: heat and transdermal fentanyl. Med Lett Drugs Ther 2009; 51:64.
   PubMed Web of Science ®Google Scholar
• Kemp PM, Harty LE. Fentanyl toxicity due to heat related excessive release from a transdermal patch (abstract)Southwest Association of Toxicologists (SAT) Annual MeetingDallas, TX2001
   Google Scholar
• Newshan G. Heat-related toxicity with the fentanyl transdermal patch. J Pain Symptom Manage 1998; 16:277–278.
   PubMed Web of Science ®Google Scholar
• Ashburn MA, Ogden LL, Zhang J, Love G, Basta SV. The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat. J Pain 2003; 4:291–297.
   PubMed Web of Science ®Google Scholar
• Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 1983; 8:422–446.
   PubMed Web of Science ®Google Scholar
• Mylan Pharmaceuticals I. Fentanyl Transdermal System: Full prescribing information and patient information. Morgantown, WV: Mylan Pharmaceuticals, Inc.; 2005:1–6.
   Google Scholar
• Schneider E, Brune K. Distribution of fentanyl in rats: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 1985; 331: 359–363.
   PubMed Web of Science ®Google Scholar
• Waters CM, Avram MJ, Krejcie TC, Henthorn TK. Uptake of fentanyl in pulmonary endothelium. J Pharmacol Exp Ther 1999; 288:157–163.
   PubMed Web of Science ®Google Scholar
• de Barros Duarte L, Dantas Moises EC, Carvalho Cavalli R, Distribution of fentanyl in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women. Eur J Clin Pharmacol 2009;
   PubMed Web of Science ®Google Scholar
• Ibrahim AE, Feldman J, Karim A, Kharasch ED. Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil. Anesthesiology 2003; 98:853–861.
   PubMed Web of Science ®Google Scholar
• Olkkola KT, Palkama VJ, Neuvonen PJ. Ritonavir's role in reducing fentanyl clearance and prolonging its half-life. Anesthesiology 1999; 91:681–685.
   PubMed Web of Science ®Google Scholar
• Hug CCJ, Murphy MR. Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology 1981; 55:369–375.
   PubMed Web of Science ®Google Scholar
• Bjorkman S, Wada DR, Stanski DR. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 1998; 88:657–667.
   PubMed Web of Science ®Google Scholar
• Haberer JP, Schoeffler P, Couderc E, Duvaldestin P. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 1982; 54:1267–1270.
   PubMed Web of Science ®Google Scholar
• Adams AP, Pybus DA. Delayed respiratory depression after use of fentanyl during anaesthesia. Br Med J 1978; 1:278–279.
   PubMed Web of Science ®Google Scholar
• Caspi J, Klausner JM, Safadi T, Amar R, Rozin RR, Merin G. Delayed respiratory depression following fentanyl anesthesia for cardiac surgery. Crit Care Med 1988; 16:238–240.
   PubMed Web of Science ®Google Scholar
• Klausner JM, Caspi J, Lelcuk S, Khazam A, Marin G, Hechtman HB, Rozin RR. Delayed muscular rigidity and respiratory depression following fentanyl anesthesia. Arch Surg 1988; 123:66–67.
   PubMed Web of Science ®Google Scholar
• Christian CM, 2nd, Waller JL, Moldenhauer CC. Postoperative rigidity following fentanyl anesthesia. Anesthesiology 1983; 58:275–277.
   PubMed Web of Science ®Google Scholar
• Stoeckel H, Hengstmann JH, Schuttler J. Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. Br J Anaesth 1979; 51:741–745.
   PubMed Web of Science ®Google Scholar
• Bjorkman S, Stanski DR, Verotta D, Harashima H. Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats. Anesthesiology 1990; 72:865–873.
   PubMed Web of Science ®Google Scholar
• Labroo RB, Paine MF, Thummel KE, Kharasch ED. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos 1997; 25:1072–1080.
   PubMed Web of Science ®Google Scholar
• Jin M, Gock SB, Jannetto PJ, Jentzen JM, Wong SH. Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol 2005; 29:590–598.
   PubMed Web of Science ®Google Scholar
• Guitton J, Buronfosse T, Desage M, Lepape A, Brazier JL, Beaune P. Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil. Biochem Pharmacol 1997; 53:1613–1619.
   PubMed Web of Science ®Google Scholar
• Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 2001; 61:2289–2307.
   PubMed Web of Science ®Google Scholar
• Feierman DE. The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro. Acta Anaesthesiol Scand 2000; 44:560–563.
   PubMed Web of Science ®Google Scholar
• Oda Y, Mizutani K, Hase I, Nakamoto T, Hamaoka N, Asada A. Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro. Br J Anaesth 1999; 82:900–903.
   PubMed Web of Science ®Google Scholar
• Palkama VJ, Neuvonen PJ, Olkkola KT. The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanyl. Br J Anaesth 1998; 81:598–600.
   PubMed Web of Science ®Google Scholar
• Hallberg P, Marten L, Wadelius M. Possible fluconazole-fentanyl interaction-a case report. Eur J Clin Pharmacol 2006; 62:491–492.
   PubMed Web of Science ®Google Scholar
• Hess R, Stiebler G, Herz A. Pharmacokinetics of fentanyl in man and the rabbit. Eur J Clin Pharmacol 1972; 4:137–141.
   PubMed Web of Science ®Google Scholar
• McClain DA, Hug CCJ. Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980; 28:106–114.
   PubMed Web of Science ®Google Scholar
• Bower S, Hull CJ. Comparative pharmacokinetics of fentanyl and alfentanil. Br J Anaesth 1982; 54:871–877.
   PubMed Web of Science ®Google Scholar
• Cartwright P, Prys-Roberts C, Gill K, Dye A, Stafford M, Gray A. Ventilatory depression related to plasma fentanyl concentrations during and after anesthesia in humans. Anesth Analg 1983; 62:966–974.
   PubMed Web of Science ®Google Scholar
• Duthie DJ, Rowbotham DJ, Wyld R, Henderson PD, Nimmo WS. Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth 1988; 60:614–618.
   PubMed Web of Science ®Google Scholar
• Garriott JC, Rodriguez R, Di Maio VJ. A death from fentanyl overdose. J Anal Toxicol 1984; 8:288–289.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Rao NG, Baird JR. A death due to self-administered fentanyl. J Anal Toxicol 1990; 14:385–387.
   PubMed Web of Science ®Google Scholar
• Pare EM, Monforte JR, Gault R, Mirchandani H. A death involving fentanyl. J Anal Toxicol 1987; 11:272–275.
   PubMed Web of Science ®Google Scholar
• Felgate HE. A suicide involving fentanyl. Bull Int Assoc For Tox 1988; 19:32–33.
   Google Scholar
• Matejczyk RJ. Fentanyl related overdose. J Anal Toxicol 1988; 12:236–238.
   PubMed Web of Science ®Google Scholar
• Levine B, Goodin JC, Caplan YH. A fentanyl fatality involving midazolam (abstract #: 19)Society of Forensic Toxicologists (SOFT) Annual MeetingChicago, IL1989
   Google Scholar
• Edinboro LE, Poklis A, Trautman D, Lowry S, Backer R, Harvey CM. Fatal fentanyl intoxication following excessive transdermal application. J Forensic Sci 1997; 42:741–743.
   PubMed Web of Science ®Google Scholar
• Lilleng PK, Mehlum LI, Bachs L, Deaths after intravenous misuse of transdermal fentanyl. J Forensic Sci 2004; 49:1364–1366.
   PubMed Web of Science ®Google Scholar
• Reeves MD, Ginifer CJ. Fatal intravenous misuse of transdermal fentanyl. Med J Aust 2002; 177:552–553.
   PubMed Web of Science ®Google Scholar
• Coon TP, Miller M, Kaylor D, Jones-Spangle K. Rectal insertion of fentanyl patches: a new route of toxicity. Ann Emerg Med 2005; 46:473.
   PubMed Web of Science ®Google Scholar
• Schneir AB, Offerman SR, Clark RF. Poisoning from the application of a scrotal transdermal fentanyl patch (abstract #38) Clin Toxicol 2001; 39:487–488.
   Google Scholar
• Marquardt KA, Tharratt RS. Inhalation abuse of fentanyl patch. J Toxicol Clin Toxicol 1994; 32:75–78.
   PubMed Web of Science ®Google Scholar
• Woodall KL, Martin TL, McLellan BA. Oral abuse of fentanyl patches (Duragesic): seven case reports. J Forensic Sci 2008; 53:222–225.
   PubMed Web of Science ®Google Scholar
• Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002–2004). J Anal Toxicol 2006; 30:603–610.
   PubMed Web of Science ®Google Scholar
• Olson KN, Luckenbill K, Thompson J, Middleton O, Geiselhart R, Mills KM, Kloss J, Apple FS. Postmortem redistribution of fentanyl in blood. Am J Clin Pathol 2010; 133:447–453.
   PubMed Web of Science ®Google Scholar
• Barrueto FJ, Howland MA, Hoffman RS, Nelson LS. The fentanyl tea bag. Vet Hum Toxicol 2004; 46:30–31.
   PubMedGoogle Scholar
• Anderson DT, Muto JJ. Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol 2000; 24:627–634.
   PubMed Web of Science ®Google Scholar
• Kuhlman JJJ, McCaulley R, Valouch TJ, Behonick GS. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol 2003; 27:499–504.
   PubMed Web of Science ®Google Scholar
• Thompson JG, Baker AM, Bracey AH, Seningen J, Kloss JS, Strobl AQ, Apple FS. Fentanyl concentrations in 23 postmortem cases from the hennepin county medical examiner's office. J Forensic Sci 2007; 52:978–981.
   PubMed Web of Science ®Google Scholar
• Baselt RC. Fentanyl. Disposition of Toxic Drugs and Chemicals in Man. 8th ed. Foster City, CA: Biomedical Publications; 2008:616–619.
   Google Scholar
• Levine B, Kauffman G, Caplan YH. The determination and distribution of fentanyl in a postmortem case (abstract #: K31)American Academy of Forensic Sciences (AAFS) Annual MeetingSan Diego, CA1987
   Google Scholar
• Winek CL, Wahba WW, Winek CL, Jr., Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001; 122:107–123.
   PubMed Web of Science ®Google Scholar
• Glidewell RN, Orr WC, Imes N. Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy. J Clin Sleep Med 2009; 5:63–64.
   PubMed Web of Science ®Google Scholar
• White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999; 94:961–972.
   PubMed Web of Science ®Google Scholar
• Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990; 73:826–830.
   PubMed Web of Science ®Google Scholar
• Jones GR. Interpretation of postmortem drug levels. In: Karch SB, ed. Postmortem Toxicology of Drugs of Abuse. New York: CRC Press; 2008:113–130.
   Google Scholar
• Pelissier-Alicot AL, Gaulier JM, Champsaur P, Marquet P. Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Toxicol 2003; 27:533–544.
   PubMed Web of Science ®Google Scholar
• Shepherd MF, Lake KD, Kamps MA. Postmortem changes and pharmacokinetics: review of the literature and case report. Ann Pharmacother 1992; 26:510–514.
   PubMed Web of Science ®Google Scholar
• Skopp G, Lutz R, Potsch L, Ganssmann B, Klinder K, Schmidt A, Aderjan R, Mattern R. An in vitro experiment for postmortem vascular permeation. The passage of morphine and morphine glucuronides across a vascular wall. J Forensic Sci 1997; 42:486–491.
   PubMed Web of Science ®Google Scholar
• Langford AM, Pounder DJ. Possible markers for postmortem drug redistribution. J Forensic Sci 1997; 42:88–92.
   PubMed Web of Science ®Google Scholar
• Hilberg T, Ripel A, Slordal L, Bjorneboe A, Morland J. The extent of postmortem drug redistribution in a rat model. J Forensic Sci 1999; 44:956–962.
   PubMed Web of Science ®Google Scholar
• Hilberg T, Bugge A, Beylich KM, Morland J, Bjorneboe A. Diffusion as a mechanism of postmortem drug redistribution: an experimental study in rats. Int J Legal Med 1992; 105:87–91.
   PubMed Web of Science ®Google Scholar
• Roy SD, Flynn GL. Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil. Pharm Res 1989; 6:147–151.
   PubMed Web of Science ®Google Scholar
• Sawyer WR, Steup DR, Martin BS, Forney RB. Cardiac blood pH as a possible indicator of postmortem interval. J Forensic Sci 1988; 33:1439–1444.
   PubMed Web of Science ®Google Scholar
• Gerostamoulos J, Drummer OH. Postmortem redistribution of morphine and its metabolites. J Forensic Sci 2000; 45:843–845.
   PubMed Web of Science ®Google Scholar
• Dalpe-Scott M, DeGouffe M, Garbutt D, Drost M. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. Can Soc Forensic Sci J 1995; 28:113–121.
   Google Scholar
• Luckenbill K, Thompson J, Middleton O, Kloss J, Apple F. Fentanyl postmortem redistribution: preliminary findings regarding the relationship among femoral blood and liver and heart tissue concentrations. J Anal Toxicol 2008; 32:639–643.
   PubMed Web of Science ®Google Scholar
• Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol 2008; 66:430–443.
   PubMed Web of Science ®Google Scholar
• Wu Chen NB, Donoghue ER, Denton JS, Mitchell BR, Ragab K, Mittel K, Bloom M. Fentanyl intoxication: Suicide by transdermal patch (abstract #: K19). American Academy of Forensic Sciences (AAFS) annual meeting 1999; Orlando, FL:
   Google Scholar
• Wiesbrock UO, Rochholz G, Franzelius C, Schwark T, Grellner W. [Excessive use of fentanyl patches as the only means of suicide]. Arch Kriminol 2008; 222:23–30.
   PubMedGoogle Scholar
• Jumbelic MI. Deaths With Transdermal Fentanyl Patches. Am J Forensic Med Pathol 2009; 31:18–21.
   Web of Science ®Google Scholar
• Liappas IA, Dimopoulos NP, Mellos E, Gitsa OE, Liappas AI, Rabavilas AD. Oral transmucosal abuse of transdermal fentanyl. J Psychopharmacol 2004; 18:277–280.
   PubMed Web of Science ®Google Scholar
• Menahem S, Shvartzman P. High-dose fentanyl patch for cancer pain. J Am Board Fam Pract 2004; 17:388–390.
   PubMedGoogle Scholar
• Bleeker CP, Bremer RC, Dongelmans DA, van Dongen RT, Crul BJ. Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report. Eur J Pain 2001; 5:325–329; discussion 329–331.
   PubMed Web of Science ®Google Scholar
• Arvanitis ML, Satonik RC. Transdermal fentanyl abuse and misuse. Am J Emerg Med 2002; 20:58–59.
   PubMed Web of Science ®Google Scholar
• SOF T. SOFT/AAFS Forensic Toxicology Laboratory Guidelines Society of Forensic Toxicologists (SOFT) 2006; 1–24.
   Google Scholar
• Hargrove VM, McCutcheon JR. Comparison of drug concentrations taken from clamped and unclamped femoral vessels. J Anal Toxicol 2008; 32:621–625.
   PubMed Web of Science ®Google Scholar
• Hilberg T, Rogde S, Morland J. Postmortem drug redistribution--human cases related to results in experimental animals. J Forensic Sci 1999; 44:3–9.
   PubMed Web of Science ®Google Scholar
• Baselt RC. Methadone. Disposition of Toxic Drugs and Chemicals in Man. 8th ed. Foster City, CA: Biomedical Publications; 2008: 941–945.
   Google Scholar
• Caplehorn JR, Drummer OH. Methadone dose and post-mortem blood concentration. Drug Alcohol Rev 2002; 21:329–333.
   PubMed Web of Science ®Google Scholar
• Milroy CM, Forrest AR. Methadone deaths: a toxicological analysis. J Clin Pathol 2000; 53:277–281.
   PubMed Web of Science ®Google Scholar
• Coopman V, Cordonnier J, Pien K, Van Varenbergh D. LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems. Forensic Sci Int 2007; 169:223–227.
   PubMed Web of Science ®Google Scholar
• Biedrzycki OJ, Bevan D, Lucas S. Fatal overdose due to prescription fentanyl patches in a patient with sickle cell/beta-thalassemia and acute chest syndrome: a case report and review of the literature. Am J Forensic Med Pathol 2009; 30:188–190.
   PubMed Web of Science ®Google Scholar
• Poklis A, Backer R. Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches. J Anal Toxicol 2004; 28:422–425.
   PubMed Web of Science ®Google Scholar
• Van Nimmen NF, Poels KL, Veulemans HA. Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 804:375–387.
   PubMed Web of Science ®Google Scholar
• Moore C, Marinetti L, Coulter C, Crompton K. Analysis of pain management drugs, specifically fentanyl, in hair: application to forensic specimens. Forensic Sci Int 2008; 176:47–50.
   PubMed Web of Science ®Google Scholar
• Oechsler S, Zimmer G, Pedal I, [Has the transdermal patch gone up in smoke? A fatal fentanyl intoxication]. Arch Kriminol 2009; 224:26–35.
   PubMedGoogle Scholar
• Lafreniere NM, Watterson JH. Detection of acute fentanyl exposure in fresh and decomposed skeletal tissues. Forensic Sci Int 2009; 185:100–106.
   PubMed Web of Science ®Google Scholar
• Kaferstein H, Sticht G. Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl. Forensic Sci Int 2000; 113:353–357.
   PubMed Web of Science ®Google Scholar
• Thomasy SM, Mama KR, Stanley SD. Comparison of liquid chromatography-mass spectrometry and radioimmunoassay for measurement of fentanyl and determination of pharmacokinetics in equine plasma. J Anal Toxicol 2008; 39:754–759.
   Google Scholar
• Watts VW, Caplan YH. Evaluation of the Coat-A-Count 125I fentanyl RIA: comparison of 125I RIA and GC/MS-SIM for quantification of fentanyl in case urine specimens. J Anal Toxicol 1990; 14:266–272.
   PubMed Web of Science ®Google Scholar